Physician profile
Gene Harris
NPI 1912926700
$1,294.58
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $228 · 2020: $79.69 · 2021: $223 · 2022: $200 · 2023: $345 · 2024: $219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $544 · Education: $19.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $544.43 |
| Education | $19.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $222.71 | 2021-2024 | Freestyle Libre 2, Freestyle Libre 3, Proclaim |
| Novo Nordisk INC | $205.11 | 2019-2024 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $193.27 | 2021-2024 | |
| Amgen INC. | $155.52 | 2019-2024 | Prolia, Evenity, Otezla |
| Lilly USA, LLC | $96.68 | 2020-2024 | Zepbound, Mounjaro, Jardiance |
| Astrazeneca Pharmaceuticals LP | $86.60 | 2020-2024 | Airsupra |
| Bayer Healthcare Pharmaceuticals INC. | $56.56 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $48.15 | 2021-2023 | |
| Medtronic USA, INC. | $44.61 | 2019 | |
| Astellas Pharma US INC | $33.91 | 2023-2024 | Veozah |
| Dexcom, INC. | $29.12 | 2021-2023 | Dexcom G6 Transmitter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.56 | 2019 | |
| Glaxosmithkline, LLC. | $22.95 | 2024 | Arexvy, Shingrix |
| Tris Pharma INC | $22.69 | 2023 | Dyanavel Xr |
| Pfizer INC. | $18.35 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $18.21 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gene Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.